Published in Contraception on June 01, 1987
Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS. Int J Womens Health (2010) 0.86
Cranioplasty with bandaging. New forms of limitation of life support and organ donation. Med Intensiva (2013) 3.26
Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation. Contraception (2004) 2.99
Induction of sex hormone binding globulin by phenytoin. Br Med J (1977) 2.13
Isolation and characterization of two distinct human rotavirus strains with G6 specificity. J Clin Microbiol (1992) 2.03
Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. Contraception (1991) 2.00
Progesterone levels in peripheral plasma during the luteal phase of the normal human menstrual cycle measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) (1969) 1.75
Outbreak of human rabies in the Peruvian jungle. Lancet (1992) 1.65
Decline in sexually transmitted disease prevalence in female Bolivian sex workers: impact of an HIV prevention project. AIDS (1998) 1.59
Depression of the progesterone levels in women treated with synthetic gestagens after ovulation. Acta Endocrinol (Copenh) (1971) 1.57
The effect of various dosages of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkey. Contraception (1976) 1.47
Acute subdural and intratemporal hematoma as a complication of percutaneous compression of the gasserian ganglion for trigeminal neuralgia. Neurocirugia (Astur) (2005) 1.45
Post-coital administration of levonorgestrel does not interfere with post-fertilization events in the new-world monkey Cebus apella. Hum Reprod (2004) 1.43
Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception (1986) 1.42
Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. Am J Obstet Gynecol (1971) 1.38
Isolation in Europe of 69 M-like (serotype 8) human rotavirus strains with either subgroup I or II specificity and a long RNA electropherotype. Arch Virol (1990) 1.37
Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod (2010) 1.25
Roles of bicarbonate, cAMP, and protein tyrosine phosphorylation on capacitation and the spontaneous acrosome reaction of hamster sperm. Biol Reprod (1999) 1.22
Characteristics of tuberculosis patients who generate secondary cases. Int J Tuberc Lung Dis (1997) 1.19
Radioimmunoassay of oestrone and oestradiol in human and bovine peripheral plasma. Acta Endocrinol (Copenh) (1972) 1.12
A five-year clinical trial of levonorgestrel silastic implants (Norplant TM). Contraception (1982) 1.11
Relationship between the plasma levels of luteinizing hormone and progesterone during the normal menstrual cycle. J Clin Endocrinol Metab (1967) 1.09
Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants. Contraception (2001) 1.07
Mechanisms of action of intrauterine devices. Obstet Gynecol Surv (1996) 1.07
Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Acta Endocrinol (Copenh) (1982) 1.04
Temporal relationships of estrogen, progesterone, and luteinizing hormone levels to ovulation in women and infrahuman primates. Am J Obstet Gynecol (1978) 1.02
Practice and patterns of estrogen treatment in climacteric women in a Swedish population. A descriptive epidemiological study. Part I. Acta Obstet Gynecol Scand (1983) 1.02
Progesterone level and response to oxytocin at term. Lancet (1968) 1.00
Serotype 3 human rotavirus strains with subgroup I specificity. J Clin Microbiol (1990) 0.99
Clinical trial with 3-keto-desogestrel subdermal implants. Contraception (1991) 0.98
Plasma levels of nonconjugated oestrone, oestradiol-17beta and oestriol during uncomplicated pregnancy. Acta Obstet Gynecol Scand Suppl (1974) 0.97
Studies on the duration of egg transport in the human oviduct. I. The time interval between ovulation and egg recovery from the uterus in normal women. Fertil Steril (1972) 0.96
Effects of continuous daily administration of 0.03 mg of d-norgestrel on the plasma levels of progesterone and the urinary excretion of oestrogens. Acta Endocrinol (Copenh) (1971) 0.96
Periovulatory progesterone concentration in the peripheral plasma of the rhesus monkey with a methodologic note on the detection of ovulation. Endocrinology (1968) 0.95
Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study. Hum Reprod (2006) 0.95
Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Ups J Med Sci (1979) 0.95
Luteinizing hormone (LH) and progesterone in plasma and LH and oestrogens in urine during 42 normal menstrual cycles. Acta Endocrinol (Copenh) (1971) 0.93
Oral contraceptives after intestinal bypass operations. JAMA (1976) 0.93
Studies on the duration of egg transport by the human oviduct. II. Ovum location at various intervals following luteinizing hormone peak. Am J Obstet Gynecol (1978) 0.92
Plasma levels of progesterone in pregnancy measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) (1969) 0.92
Sex hormone binding globulin: the carrier protein for d-norgestrel. J Clin Endocrinol Metab (1976) 0.92
Norethindrone blockade of LH release to intrapituitary infusion of hypothalamic extract. Endocrinology (1966) 0.90
Menstruation span--a time-limited risk factor for endometrial carcinoma. Acta Obstet Gynecol Scand (1986) 0.90
Relative contributions of anovulation and luteal phase defect to the reduced pregnancy rate of breastfeeding women. Fertil Steril (1992) 0.90
The risk of endometrial neoplasia and treatment with estrogens and estrogen-progestogen combinations. First results of a cohort study after one to four completed years of observation. Acta Obstet Gynecol Scand (1986) 0.90
Urinary excretion of retinol in children with acute diarrhea. Am J Clin Nutr (1995) 0.90
Radioimmunological methods for the estimation of oestrone, oestradiol-17beta and oestriol in pregnancy plasma. Acta Obstet Gynecol Scand Suppl (1974) 0.89
Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India. Postgrad Med J (2000) 0.89
Meningiomas of the basal posterior fossa. Surgical experience in 80 cases. Neurocirugia (Astur) (2004) 0.89
First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants. Contraception (1997) 0.88
Assessment of anti-inflammatory effect of 830nm laser light using C-reactive protein levels. Braz Dent J (2001) 0.87
Monophasic basal body temperature in ovulatory menstrual cycles. Am J Obstet Gynecol (1972) 0.87
Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices. Contraception (1987) 0.87
A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis. Osteoarthritis Cartilage (2007) 0.87
Lymphocytic hypophysitis with cystic MRI appearance. Acta Neurochir (Wien) (2005) 0.86
Studies on the duration of ovum transport by the human oviduct. III. Time interval between the luteinizing hormone peak and recovery of ova by transcervical flushing of the uterus in normal women. Am J Obstet Gynecol (1980) 0.86
A simplified procedure for the assay of progesterone. Acta Endocrinol Suppl (Copenh) (1970) 0.86
Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices. Contraception (1984) 0.86
Lack of clinical contraceptive efficacy of large doses of r 2323 given before implantation or after a missed period. Contraception (1975) 0.86
The influence of conjugated estrogens in radioimmunoassays using different antibodies against estradiol-17beta. Steroids (1973) 0.86
Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants. Contraception (1997) 0.85
Characteristics of estrogen-treated women. A descriptive epidemiological study of a Swedish population. Part II. Acta Obstet Gynecol Scand (1983) 0.85
Increased adhesiveness and internalization of Neisseria gonorrhoeae and changes in the expression of epithelial gonococcal receptors in the Fallopian tube of copper T and Norplant users. Hum Reprod (2001) 0.85
Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy. Br J Obstet Gynaecol (1978) 0.84
Circadian variation of basal plasma prolactin, prolactin response to suckling, and length of amenorrhea in nursing women. J Clin Endocrinol Metab (1989) 0.84
The influence of norethisterone oenanthate on ovarian function. Acta Endocrinol (Copenh) (1976) 0.84
Antiprogestins: mechanism of action and contraceptive potential. Annu Rev Pharmacol Toxicol (1996) 0.84
Plasma levels of estrogens during long-term treatment with depo-medroxyprogesterone acetate as a contraceptive agent. Contraception (1973) 0.84
Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD. Contraception (1997) 0.84
Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception (1983) 0.84
Ultrastructure of human cumulus oophorus: a transmission electron microscopic study on oviductal oocytes and fertilized eggs. Hum Reprod (1995) 0.84
Norplant consensus statement and background review. Contraception (1998) 0.83
Fertility regulation in nursing women: III. Short-term influence of a low-dose combined oral contraceptive upon lactation and infant growth. Contraception (1983) 0.83
Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat. Contraception (2003) 0.83
Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil Steril (1980) 0.83
Sperm migration into and through the oviduct following artificial insemination at different stages of the estrous cycle in the rat. Biol Reprod (1999) 0.83
Patterns of circulating progesterone concentrations during the fertile menstrual cycle and the remainder of gestation in the rhesus monkey. Endocrinology (1969) 0.83
Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Br J Obstet Gynaecol (1980) 0.83
Primary malignant melanoma of the uterine cervix: case report and review of the literature. Gynecol Obstet Invest (1991) 0.83
Progesterone regulates glycosylation in endometrium. Biochem Soc Trans (1997) 0.83
Progesterone abbreviates the nuclear retention of estrogen receptor in the rat oviduct and counteracts estrogen action on egg transport. Biol Reprod (1988) 0.82
Egg transport in the fallopian tube. Gynecol Invest (1975) 0.82
Transfer of estradiol to human milk. Am J Obstet Gynecol (1978) 0.82
A D-norgestrel-releasing IUD. Contraception (1976) 0.82
Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel. Contraception (1976) 0.82
Expression of bovine rotavirus neutralization antigen in Escherichia coli. J Gen Virol (1987) 0.82
Variability of breast sucking, associated milk transfer and the duration of lactational amenorrhoea. J Reprod Fertil (1999) 0.82
Contraceptive efficacy of lactational amenorrhea in urban Chilean women. Contraception (1991) 0.82
[Assessment of reasons for overactive bladder treatment change]. Actas Urol Esp (2011) 0.82
Ovum transport and fertility following postovulatory treatment with estradiol in rats. Biol Reprod (1979) 0.81
Periovulatory levels of plasma progesterone and luteinizing hormone in women. Acta Endocrinol (Copenh) (1969) 0.81
A seven-cell human egg recovered from the oviduct. Fertil Steril (1975) 0.81